Silberstein SD (september 2000). ”Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology”. Neurology 55 (6): sid. 754–762. doi:10.1212/WNL.55.6.754. PMID 10993991.
Bigal ME, Lipton RB (april 2009). ”Excessive opioid use and the development of chronic migraine”. Pain 142 (3): sid. 179–182. doi:10.1016/j.pain.2009.01.013. PMID 19232469.
Silberstein SD (september 2000). ”Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology”. Neurology 55 (6): sid. 754–762. doi:10.1212/WNL.55.6.754. PMID 10993991.
Bigal ME, Lipton RB (april 2009). ”Excessive opioid use and the development of chronic migraine”. Pain 142 (3): sid. 179–182. doi:10.1016/j.pain.2009.01.013. PMID 19232469.
Silberstein SD (september 2000). ”Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology”. Neurology 55 (6): sid. 754–762. doi:10.1212/WNL.55.6.754. PMID 10993991.
Bigal ME, Lipton RB (april 2009). ”Excessive opioid use and the development of chronic migraine”. Pain 142 (3): sid. 179–182. doi:10.1016/j.pain.2009.01.013. PMID 19232469.
Silberstein SD (september 2000). ”Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology”. Neurology 55 (6): sid. 754–762. doi:10.1212/WNL.55.6.754. PMID 10993991.
Bigal ME, Lipton RB (april 2009). ”Excessive opioid use and the development of chronic migraine”. Pain 142 (3): sid. 179–182. doi:10.1016/j.pain.2009.01.013. PMID 19232469.